Veeva Systems shines with 14% revenue growth, CRM adoption momentum, and Data Cloud innovations. Read why VEEV stock is a ...

JPMorgan raised the firm’s price target on Veeva (VEEV) to $249 from $218 and keeps a Neutral rating on the shares. Veeva has a substantial ...

Veeva Systems (NYSE:VEEV – Get Free Report) had its target price increased by equities researchers at JPMorgan Chase & Co. from $218.00 to $249.00 in a research note issued on Thursday,Benzinga ...

The company is successfully integrating AI into its products, with adoption picking up with larger clients and plans to ...

At this time, I would like to welcome everyone to the Veeva Systems fiscal 2025 fourth quarter and full-year results ...

Veeva (VEEV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases ...

Veeva Systems (NYSE: VEEV) today announced Veeva CRM Pulse, a data subscription that provides quarterly healthcare ...

Shares of Veeva Systems (NYSE: VEEV) are posting big gains in Thursday's trading despite broader sell-offs for the tech sector. The life-sciences software company's stock was up 10.2% as of 12:30 p.m.